Can atrophic gastritis predict stomach cancer risk?
Part of Cancer, Digestive system clinical trials.
This trial studies whether a condition called atrophic gastritis (thinning of the stomach lining) can help predict who is more likely to develop stomach cancer. It may help with early detection and prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must be willing to sign a consent form to join the study.
- You must have had stomach biopsies taken according to the updated Sydney system (a standard way to collect tissue samples).
- You cannot have had any stomach surgery before.
- You cannot have a serious ongoing disease or cancer (other than possibly stomach cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at adults with stomach lining changes—either atrophic gastritis or intestinal metaplasia—and studies how to predict who may be at risk for stomach cancer. It may help earlier identification and closer monitoring for people with these conditions.
This study tests whether a treatment called radiofrequency ablation (using heat energy to remove abnormal tissue) can help people with severe stomach lining thinning and early pre-cancer changes. It is an observational study, meaning the researchers will watch what happens to you while you get the treatment, to see if it is safe and works.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
This study looks at how often and how intensely to do follow-up stomach camera exams (endoscopy) with small biopsies for people at risk of stomach cancer. It may help personalize your follow-up schedule based on your specific stomach findings.
This study follows people with autoimmune atrophic gastritis to understand how the condition changes over time and what symptoms or complications may arise. It aims to collect information that could improve future care.
This study is looking at people at high risk for stomach cancer to see if doctors can predict from their endoscopy results whether they might develop cancer or pre-cancerous changes. It focuses on those with H. pylori infection or atrophic gastritis (thinning of the stomach lining) but no current cancer, so they can be monitored more closely.
Hear when a new Atrophic Gastritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.